NHLBI TOPMed: HyperGEN - Genetics of Left Ventricular (LV) Hypertrophy

Request Access

Anthropometry (8)

_BMI - Derived BMI (phv00404992.v1.p1)
_HT - Derived height, (self or meas) (phv00404991.v1.p1)
_RATIO - Derived waist/hip ratio (phv00404993.v1.p1)
_WT - Derived weight, (self or meas) (phv00404990.v1.p1)
ELBOW1 - Elbow breadth #1 (phv00404988.v1.p1)
ELBOW2 - Elbow breadth #2 (phv00404989.v1.p1)
HIP - Hip girth (phv00404983.v1.p1)
WAIST - Waist girth (phv00404982.v1.p1)

Biomarkers (44)

_DBP - Avg. diastolic blood pressure (phv00404972.v1.p1)
_LIPID_IR - Triglyceride/HDL ratio - insulin resistance (phv00405070.v1.p1)
_MAP - Mean arterial pressure (phv00405021.v1.p1)
_SBP - Avg. systolic blood pressure (phv00404971.v1.p1)
CHR - Total cholesterol (phv00405054.v1.p1)
CR - Creatinine (phv00405055.v1.p1)
CRCL - Creatinine Clearance (phv00405109.v1.p1)
CRCLGFR_RATIO - Urinary creatinine clearance/serum GFR ratio (phv00405048.v1.p1)
GFR - Estimated Glomular Filtration Rate (phv00405047.v1.p1)
GLUC - Glucose (phv00405056.v1.p1)
HDLC - HDL cholesterol (phv00405057.v1.p1)
INS - Insulin (phv00405058.v1.p1)
LDLC - LDL cholesterol (phv00405060.v1.p1)
MAUACR - Microalbumin: albumin creatinine ratio (phv00405076.v1.p1)
serum_NA - Sodium (phv00405062.v1.p1)
SITDST1 - 1st sitting diastolic (phv00404998.v1.p1)
SITDST2 - 2nd sitting diastolic (phv00405001.v1.p1)
SITDST3 - 3rd sitting diastolic (phv00405004.v1.p1)
SITDST4 - 4th sitting diastolic (phv00405007.v1.p1)
SITDST5 - 5th sitting diastolic (phv00405010.v1.p1)
SITDST6 - 6th sitting diastolic (phv00405013.v1.p1)
SITPUL1 - 1st sitting pulse (phv00404999.v1.p1)
SITPUL2 - 2nd sitting pulse (phv00405002.v1.p1)
SITPUL3 - 3rd sitting pulse (phv00405005.v1.p1)
SITPUL4 - 4th sitting pulse (phv00405008.v1.p1)
SITPUL5 - 5th sitting pulse (phv00405011.v1.p1)
SITPUL6 - 6th sitting pulse (phv00405014.v1.p1)
SITSYS1 - 1st sitting systolic (phv00404997.v1.p1)
SITSYS2 - 2nd sitting systolic (phv00405000.v1.p1)
SITSYS3 - 3rd sitting systolic (phv00405003.v1.p1)
SITSYS4 - 4th sitting systolic (phv00405006.v1.p1)
SITSYS5 - 5th sitting systolic (phv00405009.v1.p1)
SITSYS6 - 6th sitting systolic (phv00405012.v1.p1)
STDDST1 - 1st standing diastolic (phv00405016.v1.p1)
STDDST2 - 1st standing diastolic (phv00405019.v1.p1)
STDPUL1 - 1st standing pulse (phv00405017.v1.p1)
STDPUL2 - 1st standing pulse (phv00405020.v1.p1)
STDSYS1 - 1st standing systolic (phv00405015.v1.p1)
STDSYS2 - 1st standing systolic (phv00405018.v1.p1)
TRR - Triglycerides (phv00405064.v1.p1)
URIC - Serum Uric acid (phv00405065.v1.p1)
URIC_ACID_1 - Urine Uric Acid A (phv00405107.v1.p1)
URIC_ACID_2 - Urine Uric Acid B (phv00405108.v1.p1)
URIC_ACID_AVG - Urine uric acid average (phv00405075.v1.p1)

Demographics (4)

AGE - Age at clinic visit (phv00404970.v1.p1)
SEX - Sex (phv00404980.v1.p1)
SEX - Sex (phv00404965.v1.p1)
STRKAGE - Age of 1st diagnosed stroke (phv00405106.v1.p1)

Disease Events (9)

_DBFINAL - Final diabetes status (phv00404978.v1.p1)
_HTFINAL - Final hypertension status (Using _NANTIHT) (phv00404976.v1.p1)
_HTFINALPLUS - Final hypertension status (Using _NANTIHTPLUS) (phv00404977.v1.p1)
AFFECTION_STATUS - Case control status of the subject (phv00404958.v1.p1)
BYP - Bypass/angioplasty/balloon/stent (phv00405103.v1.p1)
BYPAGE - Age of bypass/angioplasty/balloon/stent (phv00405104.v1.p1)
HADX - Heart attack (phv00405101.v1.p1)
HADXAGE - Age of 1st heart attack (phv00405102.v1.p1)
STRK - Stroke (phv00405105.v1.p1)

Geography (1)

CENTER - Field Center (phv00404969.v1.p1)

Medications (11)

_NANTIHT - Number of anti-hypertensive medications (phv00404974.v1.p1)
_NANTIHTPLUS - Number of anti-hypertensive/diuretic medications (phv00404975.v1.p1)
ACE - ACE inhibitors (phv00405044.v1.p1)
ALPHABLK - Alpha blockers (phv00405046.v1.p1)
ANG2 - Angiotensin II receptor antagonist (phv00405045.v1.p1)
ANTIDIAB - Antidiabetic (phv00405039.v1.p1)
ANTILIP - Antihyperlipidemic (phv00405040.v1.p1)
BETA_BLK - Beta blockers (phv00405042.v1.p1)
CA_BLK - Calcium blockers (phv00405043.v1.p1)
DIURETIC - Diuretics (phv00405041.v1.p1)
HORMONE - Female hormones (phv00405082.v1.p1)

Race and Ethnicity (1)

RACE - Hypergen racial category (phv00404981.v1.p1)

Reproductive Health (6)

HORMNAGE - Apprx. age of first usage of hormone (phv00405083.v1.p1)
YR6ECLAMPS - Pre/eclampsia during pregnancy? (phv00405081.v1.p1)
YR6MENOPAUS - Reached menopause? (phv00405077.v1.p1)
YR6N_TERM - Number of pregnancies carried to term (phv00405079.v1.p1)
YR6PREG_HT - Hypertension during pregnancy? (phv00405080.v1.p1)
YR6PREGTERM - Ever had pregnancy carried to term? (phv00405078.v1.p1)

Study Administration (1)

FAST_TIM - Fasting time (phv00405100.v1.p1)

Substance Use (15)

ALCOHOL - Ever drink alcohol? (phv00405085.v1.p1)
BEER - Drink beer? (phv00405087.v1.p1)
BEERCANS - Average number of cans of beer/week (phv00405089.v1.p1)
BEERDAYS - How many days per week do you drink beer? (phv00405088.v1.p1)
CIGDAY - How many cigarettes/day do you smoke? (phv00405099.v1.p1)
DRINKNOW - Drink alcohol now? (phv00405086.v1.p1)
LIQR - Drink liquor or spirits? (phv00405093.v1.p1)
LIQRDAYS - How many days per week do you drink liquor? (phv00405094.v1.p1)
LIQRSHOT - Average number of shots of liquor/week (phv00405095.v1.p1)
QUITAGE - Age quit smoking (phv00405098.v1.p1)
SMOKE - Ever smoke cigarettes? (phv00405096.v1.p1)
SMOKENOW - Smoke cigarettes now? (phv00405097.v1.p1)
WINE - Drink wine? (phv00405090.v1.p1)
WINEDAYS - How many days per week do you drink wine? (phv00405091.v1.p1)
WINEGLAS - Average number of glasses of wine/week (phv00405092.v1.p1)

Other (64)

_HOMA - Homeostasis model assessment insulin resistance index (phv00405069.v1.p1)
_HOMA2B - HOMA 2 - steady state beta cell function (%B) (phv00405049.v1.p1)
_HOMA2IR - HOMA 2 - insulin resistance (phv00405051.v1.p1)
_HOMA2S - HOMA 2 - insulin sensitivity (%S) (phv00405050.v1.p1)
_PBF_EL - Percent body fat, elderly (phv00404996.v1.p1)
_PBF_LK - Percent body fat, Lukaski (phv00404995.v1.p1)
_PBF_NA - Percent body fat, Native American (phv00404994.v1.p1)
AGT - Angiotensinogen (phv00405067.v1.p1)
ALB - Albumin (phv00405052.v1.p1)
ALDO_1 - Serum aldosterone, first measurement (phv00405071.v1.p1)
ALDO_2 - Serum aldosterone, second measurement (phv00405072.v1.p1)
ALDO_3 - Serum aldosterone, third measurement (phv00405073.v1.p1)
ALDO_AVE - Serum aldosterone, average of 3 measurements (phv00405074.v1.p1)
ANALYTE_TYPE - Analyte Type (phv00405113.v1.p1)
ANP - Atrial natriuretic peptide (phv00405068.v1.p1)
AR2D - Aortic root (2D) (phv00405028.v1.p1)
BODY_SITE - Body site where sample was collected (phv00405112.v1.p1)
CA - Calcium (phv00405053.v1.p1)
CONSENT - Consent group as determined by DAC (phv00404957.v1.p1)
EDUC - Highest grade.education level completed (phv00405084.v1.p1)
EF - Left ventricular ejection fraction (phv00405036.v1.p1)
FAMILY_ID - Family ID (phv00404961.v1.p1)
FATHER - Father's Subject ID (phv00404964.v1.p1)
FS - Fractional shortening (phv00405034.v1.p1)
Funding_Source - Project funding source (phv00405116.v1.p1)
IS_TUMOR - Tumor status (phv00405114.v1.p1)
KK - Potassium (phv00405059.v1.p1)
labid - Lab ID (phv00404979.v1.p1)
LASD2D - Left atrial systolic dimension (2D) (phv00405029.v1.p1)
LVH274 - Lvm/ht2.7 >51=LVH non gender-spec phase 2 (phv00405110.v1.p1)
LVIDD - Left ventrical internal diastolic dimension (phv00405030.v1.p1)
LVMASS - Left ventricular mass (phv00405032.v1.p1)
LVMHT27 - Left ventricular mass/m^2.7 (phv00405035.v1.p1)
MG - Magnesium (phv00405061.v1.p1)
MOTHER - Mother's Subject ID (phv00404963.v1.p1)
MVEA - Mve/Mva (phv00405038.v1.p1)
MWS - Midwall shortening (phv00405037.v1.p1)
MZ_TWIN_ID - Twin ID for monozygotic twins. A twin ID is not provided for dizygotic twins or multiples. (phv00404966.v1.p1)
PHOS - Phosphorus (phv00405063.v1.p1)
PWTD - Diastolic posterior wall thickness (phv00405031.v1.p1)
RENIN - Renin (phv00405066.v1.p1)
RWT - Relative wall thickness (phv00405033.v1.p1)
SAMPLE_ID - De-identified Sample ID (phv00405111.v1.p1)
SAMPLE_ID - Sample ID (phv00404968.v1.p1)
SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00405115.v1.p1)
SITMAP1 - 1st sitting MAP (phv00405022.v1.p1)
SITMAP2 - 2nd sitting MAP (phv00405023.v1.p1)
SITMAP3 - 3rd sitting MAP (phv00405024.v1.p1)
SITMAP4 - 4th sitting MAP (phv00405025.v1.p1)
SITMAP5 - 5th sitting MAP (phv00405026.v1.p1)
SITMAP6 - 6th sitting MAP (phv00405027.v1.p1)
SOURCE_SUBJECT_ID - Subject ID used in the SUBJECT_SOURCE repository (phv00404960.v1.p1)
Study_Name - TOPMed-assigned short study name (1:1 with TOPMed phs number) (phv00405119.v1.p1)
SUBJECT_ID - Subject identifier (phv00404973.v1.p1)
SUBJECT_ID - Unique Subject ID (phv00404962.v1.p1)
SUBJECT_ID - Subject ID (phv00404956.v1.p1)
SUBJECT_ID - Subject ID (phv00404967.v1.p1)
SUBJECT_SOURCE - Repository name for dbGaP study also containing this individual (phv00404959.v1.p1)
SUBSCAP1 - Subscapular thickness #1 (phv00404986.v1.p1)
SUBSCAP2 - Subscapular thickness #1 (phv00404987.v1.p1)
TOPMed_Phase - TOPMed Phase (phv00405117.v1.p1)
TOPMed_Project - TOPMed Project that funded sequencing (phv00405118.v1.p1)
TRICEPS1 - Triceps thickness #1 (phv00404984.v1.p1)
TRICEPS2 - Triceps thickness #2 (phv00404985.v1.p1)